Veronica Balatti

3.0k total citations
41 papers, 1.9k citations indexed

About

Veronica Balatti is a scholar working on Genetics, Molecular Biology and Immunology. According to data from OpenAlex, Veronica Balatti has authored 41 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Genetics, 20 papers in Molecular Biology and 17 papers in Immunology. Recurrent topics in Veronica Balatti's work include Chronic Lymphocytic Leukemia Research (22 papers), MicroRNA in disease regulation (13 papers) and RNA modifications and cancer (11 papers). Veronica Balatti is often cited by papers focused on Chronic Lymphocytic Leukemia Research (22 papers), MicroRNA in disease regulation (13 papers) and RNA modifications and cancer (11 papers). Veronica Balatti collaborates with scholars based in United States, Italy and Switzerland. Veronica Balatti's co-authors include Carlo M. Croce, Yuri Pekarsky, Laura Z. Rassenti, Thomas J. Kipps, Alexey Palamarchuk, Angelo Veronese, Dario Veneziano, Lara Rizzotto, Rosa Visone and Mario Acunzo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Applied and Environmental Microbiology.

In The Last Decade

Veronica Balatti

40 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Veronica Balatti United States 25 1.3k 1.1k 415 367 237 41 1.9k
Nadia Felli Italy 19 2.3k 1.7× 1.9k 1.8× 310 0.7× 377 1.0× 102 0.4× 30 2.9k
Zongdong Li United States 14 1.2k 0.9× 987 0.9× 144 0.3× 473 1.3× 199 0.8× 26 1.9k
Raphael Koch Germany 11 753 0.6× 375 0.3× 123 0.3× 259 0.7× 210 0.9× 33 1.2k
Tania Díaz Spain 21 1.2k 0.9× 1.0k 0.9× 95 0.2× 157 0.4× 132 0.6× 53 1.7k
Jérôme Paggetti Luxembourg 18 1.2k 0.9× 694 0.6× 178 0.4× 691 1.9× 87 0.4× 38 1.9k
Christian S. R. Hatton United Kingdom 10 1.7k 1.3× 1.7k 1.5× 67 0.2× 249 0.7× 282 1.2× 14 2.2k
Geert Harms Netherlands 19 1.0k 0.8× 846 0.8× 69 0.2× 358 1.0× 221 0.9× 25 1.6k
Laura Belver United States 11 897 0.7× 404 0.4× 164 0.4× 388 1.1× 211 0.9× 19 1.5k
Darshna Bhatt United States 13 1.3k 1.0× 1.2k 1.1× 69 0.2× 416 1.1× 123 0.5× 15 2.1k
Mark A. Wechser United States 8 755 0.6× 219 0.2× 155 0.4× 600 1.6× 355 1.5× 9 1.6k

Countries citing papers authored by Veronica Balatti

Since Specialization
Citations

This map shows the geographic impact of Veronica Balatti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veronica Balatti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veronica Balatti more than expected).

Fields of papers citing papers by Veronica Balatti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Veronica Balatti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veronica Balatti. The network helps show where Veronica Balatti may publish in the future.

Co-authorship network of co-authors of Veronica Balatti

This figure shows the co-authorship network connecting the top 25 collaborators of Veronica Balatti. A scholar is included among the top collaborators of Veronica Balatti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Veronica Balatti. Veronica Balatti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tili, Esmerina, Hajime Otsu, Alexey Palamarchuk, et al.. (2024). MiR-155 -targeted IcosL controls tumor rejection. Proceedings of the National Academy of Sciences. 121(29). e2408649121–e2408649121. 2 indexed citations
2.
Ferlita, Alessandro La, Giovanni Nigita, Liudmyla Tsyba, et al.. (2023). Expression signature of human endogenous retroviruses in chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences. 120(44). e2307593120–e2307593120. 7 indexed citations
3.
Balatti, Veronica & Carlo M. Croce. (2022). Small Non-Coding RNAs in Leukemia. Cancers. 14(3). 509–509. 8 indexed citations
4.
Farina, Nicholas H., Caroline Adams, Deli Hong, et al.. (2020). Identification of tRNA‐derived small RNA (tsRNA) responsive to the tumor suppressor, RUNX1, in breast cancer. Journal of Cellular Physiology. 235(6). 5318–5327. 58 indexed citations
5.
Balatti, Veronica & Carlo M. Croce. (2019). MicroRNA dysregulation and multi-targeted therapy for cancer treatment. Advances in Biological Regulation. 75. 100669–100669. 25 indexed citations
6.
Balatti, Veronica, Steve Oghumu, Arianna Bottoni, et al.. (2018). MicroRNA Profiling of Salivary Duct Carcinoma Versus Her2/Neu Overexpressing Breast Carcinoma Identify miR-10a as a Putative Breast Related Oncogene. Head and Neck Pathology. 13(3). 344–354. 13 indexed citations
7.
Balatti, Veronica, Luisa Tomasello, Laura Z. Rassenti, et al.. (2018). miR-125a and miR-34a expression predicts Richter syndrome in chronic lymphocytic leukemia patients. Blood. 132(20). 2179–2182. 26 indexed citations
8.
Balatti, Veronica, Yuri Pekarsky, & Carlo M. Croce. (2017). Role of the tRNA-Derived Small RNAs in Cancer: New Potential Biomarkers and Target for Therapy. Advances in cancer research. 135. 173–187. 66 indexed citations
9.
Rassenti, Laura Z., Veronica Balatti, Emanuela M. Ghia, et al.. (2017). MicroRNA dysregulation to identify therapeutic target combinations for chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences. 114(40). 10731–10736. 47 indexed citations
10.
Pekarsky, Yuri, Veronica Balatti, & Carlo M. Croce. (2017). BCL2 and miR-15/16: from gene discovery to treatment. Cell Death and Differentiation. 25(1). 21–26. 152 indexed citations
11.
Balatti, Veronica, et al.. (2016). Novel Mechanisms of Regulation of miRNAs in CLL. Trends in cancer. 2(3). 134–143. 32 indexed citations
12.
Balatti, Veronica, et al.. (2013). miR Deregulation in CLL. Advances in experimental medicine and biology. 792. 309–325. 22 indexed citations
13.
Zanesi, Nicola, Veronica Balatti, Arianna Bottoni, Carlo M. Croce, & Yuri Pekarsky. (2012). Novel Insights in Molecular Mechanisms of CLL. Current Pharmaceutical Design. 18(23). 3363–3372. 13 indexed citations
14.
Costinean, Stefan, et al.. (2012). Primary intrathyroidal paraganglioma: histopathology and novel molecular alterations. Human Pathology. 43(12). 2371–2375. 7 indexed citations
15.
Balatti, Veronica, Manuela Ferracin, Angelo Veronese, et al.. (2011). MicroRNAs Dysregulation in Human Malignant Pleural Mesothelioma. Journal of Thoracic Oncology. 6(5). 844–851. 71 indexed citations
16.
Balatti, Veronica, Arianna Bottoni, Alexey Palamarchuk, et al.. (2011). NOTCH1 mutations in CLL associated with trisomy 12. Blood. 119(2). 329–331. 134 indexed citations
17.
Visone, Rosa, Laura Z. Rassenti, Angelo Veronese, et al.. (2009). Karyotype-specific microRNA signature in chronic lymphocytic leukemia. Blood. 114(18). 3872–3879. 150 indexed citations
18.
Balatti, Veronica, Roberto Guaschino, Alfredo Corallini, et al.. (2008). Simian virus 40 sequences in blood specimens from healthy individuals of Casale Monferrato, an industrial town with a history of asbestos pollution. Journal of Infection. 58(1). 53–60. 29 indexed citations
19.
Martini, Fernanda, et al.. (2007). Simian virus 40 in humans. Infectious Agents and Cancer. 2(1). 13–13. 54 indexed citations
20.
Martini, Fernanda, Veronica Balatti, Francesco Lupidi, Massimo Gerosa, & Mauro Tognon. (2007). Glioblastoma in a patient with professional exposure to the oncogenic polyomavirus SV40. 3(1). 29–32. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026